Table 1.
REMEMBER study cohort
| HC | SCD | MCI | ADD | Total | |
| Center 1 | 44 | 38 | 51 | 86 | 295 |
| Center 2 | 2 | 76 | 14 | 29 | |
| Center 3 | 32 | 13 | 14 | 89 | |
| Center 4 | 43 | 54 | 54 | ||
| Center 5 | 26 | 17 | 38 | 81 | |
| Center 6 | 2 | 96 | 65 | 163 | |
| Center 7 | 20 | 40 | 39 | 99 | |
| Center 8 | 2 | 8 | 10 | ||
| STUDY COHORT | 90 | 93 | 357 | 280 | 820 |
| Complete rejection post – QC | 1 | 4 | 36 | 30 | 71 |
| WB volumes – approved | 89 | 89 | 321 | 250 | 749 |
| All volumes – approved | 88 | 88 | 317 | 204 | 697 |
Number of subjects per disease stage (cognitively healthy control (HC), subjective cognitive decline (SCD), mild cognitive impairment (MCI) and Alzheimer’s disease dementia (ADD) patients) for each participating center. Study cohort and approved volumes (only whole brain (WB) and all volumes) after quality control (post-QC) are highlighted in bold.